{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:56:20Z","timestamp":1792803380338,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.yexcr.2020.112009","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T21:52:28Z","timestamp":1587073948000},"page":"112009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo"],"prefix":"10.1016","volume":"392","author":[{"given":"Rohit P.","family":"Nagare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smarakan","family":"Sneha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syama","family":"Krishnapriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchan","family":"Murhekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekar","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aboo","family":"Shabna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trivadi S.","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"728","key":"10.1016\/j.yexcr.2020.112009_bib1","first-page":"736","article-title":"Ovarian cancer care: it's time for \"personalized\" approaches","volume":"24","author":"Aletti","year":"2010","journal-title":"Oncology"},{"key":"10.1016\/j.yexcr.2020.112009_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.onc.1209827","article-title":"RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer","volume":"26","author":"Bignone","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2020.112009_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2020.112009_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13048-019-0590-5","article-title":"Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer","volume":"12","author":"Connor","year":"2019","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.yexcr.2020.112009_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.yexcr.2020.112009_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.humpath.2016.08.005","article-title":"CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells","volume":"58","author":"Davidson","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yexcr.2020.112009_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nbt0109-44","article-title":"Looking ahead in cancer stem cell research","volume":"27","author":"Dick","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2020.112009_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2559.2001.01042.x","article-title":"Precursor lesions of ovarian epithelial malignancy","volume":"38","author":"Feeley","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.yexcr.2020.112009_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature11979","article-title":"Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche","volume":"495","author":"Flesken-Nikitin","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2020.112009_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.yexcr.2020.112009_bib11","first-page":"2259","article-title":"Tumor heterogeneity","volume":"44","author":"Heppner","year":"1984","journal-title":"Can. Res."},{"key":"10.1016\/j.yexcr.2020.112009_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.yexcr.2020.112009_bib13","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/nprot.2012.097","article-title":"Primary culture and immortalization of human fallopian tube secretory epithelial cells","volume":"7","author":"Karst","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.yexcr.2020.112009_bib14","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00404-017-4529-z","article-title":"Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?","volume":"296","author":"Klotz","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.yexcr.2020.112009_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10147-016-1033-6","article-title":"Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance","volume":"22","author":"Krishna Priya","year":"2017","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2020.112009_bib16","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","article-title":"Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer","volume":"9","author":"Landen","year":"2010","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.yexcr.2020.112009_bib17","first-page":"155","article-title":"Establishment of ovarian cancer cell lines","volume":"39","author":"Langdon","year":"2001","journal-title":"Methods Mol. Med."},{"issue":"4","key":"10.1016\/j.yexcr.2020.112009_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2020.112009_bib19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","author":"Lonsdale","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2020.112009_bib20","doi-asserted-by":"crossref","first-page":"135039","DOI":"10.1155\/2011\/135039","article-title":"Phenotypic heterogeneity of breast cancer stem cells","volume":"2011","author":"Lorico","year":"2011","journal-title":"Journal of Oncology"},{"key":"10.1016\/j.yexcr.2020.112009_bib21","series-title":"Unigene-the NCBI handbook [internet]. Bethesda (MD): national center for Biotechnology information (US)","author":"Lukas Wagner","year":"2013"},{"key":"10.1016\/j.yexcr.2020.112009_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ygyno.2015.05.040","article-title":"In vivo tumor growth of high-grade serous ovarian cancer cell lines","volume":"138","author":"Mitra","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2020.112009_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1574888X11666160607211436","article-title":"Cancer stem cells - are surface markers alone sufficient?","volume":"12","author":"Nagare","year":"2017","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.yexcr.2020.112009_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biocel.2019.02.003","article-title":"Analysis of hematopoietic stem cells using a composite approach","volume":"109","author":"Nagare","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.yexcr.2020.112009_bib25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/ncb3000","article-title":"Lgr5 marks stem\/progenitor cells in ovary and tubal epithelia","volume":"16","author":"Ng","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yexcr.2020.112009_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2020.112009_bib27","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1038\/s41598-019-42954-9","article-title":"ATP-binding cassette transporters substantially reduce estimates of ALDH-positive cancer cells based on aldefluor and AldeRed588 assays","volume":"9","author":"Park","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2020.112009_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond","volume":"10","author":"Pasquale","year":"2010","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.yexcr.2020.112009_bib29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0020-7292(03)00225-X","article-title":"Cancer in women","volume":"82","author":"Pecorelli","year":"2003","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.yexcr.2020.112009_bib30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Canc. Cell"},{"key":"10.1016\/j.yexcr.2020.112009_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2020.112009_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.yexcr.2020.112009_bib33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejca.2017.04.016","article-title":"Exploring the clonal evolution of CD133\/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC).","volume":"79","author":"Ruscito","year":"2017","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.yexcr.2020.112009_bib34","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih Ie","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2020.112009_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/cell.2019.0005","article-title":"Analysis of human stem cell transcription factors","volume":"21","author":"Sneha","year":"2019","journal-title":"Cell. Reprogr."},{"key":"10.1016\/j.yexcr.2020.112009_bib36","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00262-017-2049-0","article-title":"Therapeutic antibodies against cancer stem cells: a promising approach","volume":"66","author":"Sneha","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.yexcr.2020.112009_bib37","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1073\/pnas.1005529108","article-title":"Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells","volume":"108","author":"Stewart","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2020.112009_bib38","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","article-title":"Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness","volume":"103","author":"Szotek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2020.112009_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1875036201004010005","article-title":"Amazonia!: an online resource to google and visualize public human whole Genome expression data","author":"Tanguy Le Carrour","year":"2010","journal-title":"Open Bioinf. J."},{"key":"10.1016\/j.yexcr.2020.112009_bib40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nature12777","article-title":"Dedifferentiation of committed epithelial cells into stem cells in vivo","volume":"503","author":"Tata","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2020.112009_bib41","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1002\/stem.2021","article-title":"Development of a fluorescent reporter system to delineate cancer stem cells in triple-negative breast cancer","volume":"33","author":"Thiagarajan","year":"2015","journal-title":"Stem Cell."},{"key":"10.1016\/j.yexcr.2020.112009_bib42","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1158\/1078-0432.CCR-07-4959","article-title":"Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma","volume":"14","author":"Tone","year":"2008","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.yexcr.2020.112009_bib43","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","article-title":"A human protein atlas for normal and cancer tissues based on antibody proteomics","volume":"4","author":"Uhlen","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.yexcr.2020.112009_bib44","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer Genome atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2020.112009_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1478-811X-8-6","article-title":"Cancer stem cells in solid tumors: elusive or illusive?","volume":"8","author":"Welte","year":"2010","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.yexcr.2020.112009_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbrc.2011.04.098","article-title":"Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia","volume":"409","author":"Yamazaki","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2020.112009_bib47","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3346\/jkms.2013.28.10.1443","article-title":"Expression and clinicopathological significance of CD9 in gastrointestinal stromal tumor","volume":"28","author":"Yang","year":"2013","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.yexcr.2020.112009_bib48","doi-asserted-by":"crossref","first-page":"17266","DOI":"10.1073\/pnas.1419599111","article-title":"Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2020.112009_bib49","first-page":"2745","article-title":"CD24, COX-2, and p53 in epithelial ovarian cancer and its clinical significance","volume":"4","author":"Zhu","year":"2012","journal-title":"Front. Biosci."},{"key":"10.1016\/j.yexcr.2020.112009_bib50","article-title":"Expression of cancer stem cell markers CD24, EPHA1 and CD9 and their correlation with clinical outcome in epithelial ovarian tumours","author":"Nagare","year":"2020","journal-title":"Canc. Biomark"},{"issue":"7","key":"10.1016\/j.yexcr.2020.112009_bib51","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1021\/pr800056j","article-title":"Plasma membrane proteomics of human embryonic stem cells and human embryonal carcinoma cells","volume":"7","author":"Dormeyer","year":"2008","journal-title":"J. Proteome Res."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482720302317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482720302317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:30:42Z","timestamp":1757997042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482720302317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0014482720302317"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2020.112009","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2020.112009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112009"}}